Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 SalesVaccine biotechnology company Novavax (
NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 16.6% year on year to $70.45 million. The company expects the full year’s revenue to be around $1.05 billion, close to analysts’ estimates. Its non-GAAP loss of $1.25 per share was 10.5% below analysts’ consensus estimates.
Nutanix (NASDAQ:NTNX) Misses Q3 CY2025 Revenue EstimatesHybrid multicloud computing company Nutanix (
NASDAQ:NTNX) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 13.5% year on year to $670.6 million. Next quarter’s revenue guidance of $710 million underwhelmed, coming in 5.1% below analysts’ estimates. Its non-GAAP profit of $0.41 per share was in line with analysts’ consensus estimates.
Mobileye (NASDAQ:MBLY) Delivers Impressive Q3 CY2025Autonomous driving technology company Mobileye (
NASDAQ:MBLY) announced better-than-expected revenue in Q3 CY2025, with sales up 3.7% year on year to $504 million. The company’s full-year revenue guidance of $1.87 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
Martin Marietta Materials (NYSE:MLM) Misses Q3 CY2025 Revenue EstimatesConstruction materials supplier Martin Marietta Materials (
NYSE:MLM) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 12.4% year on year to $1.85 billion. The company’s full-year revenue guidance of $6.16 billion at the midpoint came in 11.7% below analysts’ estimates. Its non-GAAP profit of $6.85 per share was 2.5% above analysts’ consensus estimates.
Motorola Solutions (NYSE:MSI) Beats Q3 CY2025 Sales ExpectationsPublic safety technology company Motorola Solutions (
NYSE:MSI) announced better-than-expected revenue in Q3 CY2025, with sales up 7.8% year on year to $3.01 billion. Its non-GAAP profit of $4.06 per share was 5.5% above analysts’ consensus estimates.
MediaAlpha (NYSE:MAX) Posts Better-Than-Expected Sales In Q3 CY2025Insurance customer acquisition platform MediaAlpha (
NYSE:MAX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 18.3% year on year to $306.5 million. On the other hand, next quarter’s revenue guidance of $290 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 8.2% above analysts’ consensus estimates.
Ingredion (NYSE:INGR) Misses Q3 CY2025 Revenue EstimatesFood ingredient solutions provider Ingredion (
NYSE:INGR) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 2.9% year on year to $1.82 billion. Its non-GAAP profit of $2.75 per share was 4.8% below analysts’ consensus estimates.
Howard Hughes Holdings (NYSE:HHH) Reports Strong Q3 CY2025Real estate developer Howard Hughes Holdings (
NYSE:HHH) announced better-than-expected revenue in Q3 CY2025, with sales up 19.3% year on year to $390.2 million. Its GAAP profit of $2.02 per share was 32% above analysts’ consensus estimates.
Heritage Insurance Holdings’s (NYSE:HRTG) Q3 CY2025 Sales Beat EstimatesProperty insurance provider Heritage Insurance Holdings (
NYSE:HRTG) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $212.5 million. Its non-GAAP profit of $1.56 per share was significantly above analysts’ consensus estimates.
Halozyme Therapeutics (NASDAQ:HALO) Reports Bullish Q3 CY2025Biopharmaceutical drug delivery company Halozyme Therapeutics (
NASDAQ:HALO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 22.1% year on year to $354.3 million. The company’s full-year revenue guidance of $1.34 billion at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $1.72 per share was 5.5% above analysts’ consensus estimates.
Garrett Motion (NASDAQ:GTX) Reports Bullish Q3 CY2025Turbocharger technology company Garrett Motion (
NYSE:GTX) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.2% year on year to $902 million. The company’s full-year revenue guidance of $3.55 billion at the midpoint came in 0.6% above analysts’ estimates. Its GAAP profit of $0.38 per share was 19.1% above analysts’ consensus estimates.
3 Low-Volatility Stocks Walking a Fine LineLow-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
3 Profitable Stocks with Warning SignsWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Semiconductor Stocks with Open QuestionsSemiconductors are the picks and shovels of modern technology. The amount of data we ingest is also increasing exponentially, leading to elevated demand for chips with more processing power.
This secular trend bodes well for the industry, which has posted a six-month gain of 32.6% and beat the S&P 500 by 21.3 percentage points.
2 Volatile Stocks Worth Your Attention and 1 Facing ChallengesMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
1 Cash-Heavy Stock on Our Buy List and 2 Facing ChallengesA cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
3 Profitable Stocks Walking a Fine LineEven if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Large-Cap Stocks to Research FurtherLarge-cap stocks usually command their industries because they have the scale to drive market trends.
The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
1 Cash-Producing Stock to Target This Week and 2 We Turn DownGenerating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We AvoidWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
2 Profitable Stocks to Consider Right Now and 1 We Turn DownNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Low-Volatility Stocks with Questionable FundamentalsLow-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
1 Cash-Producing Stock to Keep an Eye On and 2 We AvoidA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 Unpopular Stock That Deserves Some Love and 2 We Find RiskyWhen Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
1 Healthcare Stock to Target This Week and 2 We QuestionHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately
as healthcare stocks were up 11.5% over the past six months, almost identical to the S&P 500.
2 Healthcare Stocks for Long-Term Investors and 1 We Find RiskyPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately -
over the past six months, healthcare stocks have gained 11.5%, nearly mirrorring the S&P 500.
1 Unpopular Stock That Deserves a Second Chance and 2 Facing HeadwindsWall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
2 Growth Stocks to Add to Your Roster and 1 We AvoidGrowth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
3 Overrated Stocks We Steer Clear OfThe stocks featured in this article have all approached their 52-week highs.
When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
3 Value Stocks That Concern UsValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
2 Profitable Stocks with Promising Prospects and 1 Facing ChallengesWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 of Wall Street’s Favorite Stocks We Keep Off Our RadarWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
1 Russell 2000 Stock Worth Your Attention and 2 We Brush OffThe Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
2 Unpopular Stocks That Deserve Some Love and 1 That UnderwhelmWall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
1 Profitable Stock Worth Your Attention and 2 We Turn DownEven if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
1 Cash-Producing Stock Worth Your Attention and 2 We QuestionA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 Dow Jones Stock Worth Your Attention and 2 We Brush OffThe Dow Jones (^DJI) is home to corporate giants, but size alone doesn’t guarantee success.
A few of these companies are struggling with weak fundamentals, paradigm shifts, or poor execution.
1 Profitable Stock with Exciting Potential and 2 Facing HeadwindsNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Volatile Stocks We Find RiskyA highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
3 Overrated Stocks We Approach with CautionEach stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
3 High-Flying Stocks We Think Twice AboutExpensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match.
The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
3 Mid-Cap Stocks with Questionable FundamentalsMid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
1 Russell 2000 Stock on Our Buy List and 2 We IgnoreSmall-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
3 Low-Volatility Stocks We’re Skeptical OfStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
1 Russell 2000 Stock with Exciting Potential and 2 We IgnoreSmall-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 Facing HeadwindsThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 Momentum Stock to Target This Week and 2 That UnderwhelmThe stocks featured in this article have all approached their 52-week highs.
When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
3 Russell 2000 Stocks We Approach with CautionThe Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
1 Volatile Stock with Solid Fundamentals and 2 We Find RiskyMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
3 Unprofitable Stocks with Open QuestionsRunning at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
3 Cash-Heavy Stocks We Find RiskyCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
3 Value Stocks We’re Skeptical OfThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 S&P 500 Stocks We Keep Off Our RadarThe S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
3 Unprofitable Stocks We Find RiskyUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
1 Small-Cap Stock with Exciting Potential and 2 We QuestionSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
3 Volatile Stocks We Steer Clear OfVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
1 Small-Cap Stock with Exciting Potential and 2 We Turn DownSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
2 Volatile Stocks with Promising Prospects and 1 We IgnoreVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
2 Cash-Producing Stocks for Long-Term Investors and 1 Facing ChallengesWhile strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
3 Small-Cap Stocks with Warning SignsMany small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
3 Stocks Under $50 We Think Twice AboutStocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges.
However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
3 of Wall Street’s Favorite Stocks Worth Your AttentionThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
3 Reasons to Sell CTS and 1 Stock to Buy InsteadSince July 2025, CTS has been in a holding pattern, posting a small loss of 1.1% while floating around $42.87. The stock also fell short of the S&P 500’s 11.2% gain during that period.
Ladder Capital (LADR): Buy, Sell, or Hold Post Q3 Earnings?Since July 2025, Ladder Capital has been in a holding pattern, posting a small return of 1.2% while floating around $10.99. The stock also fell short of the S&P 500’s 11.2% gain during that period.
2 Reasons to Avoid WK and 1 Stock to Buy InsteadOver the past six months, Workiva has been a great trade, beating the S&P 500 by 15.1%. Its stock price has climbed to $86.29, representing a healthy 26.4% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Sell CDW and 1 Stock to Buy InsteadCDW’s stock price has taken a beating over the past six months, shedding 24.8% of its value and falling to $136.22 per share. This may have investors wondering how to approach the situation.
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how to approach the situation.
2 Reasons PGNY is Risky and 1 Stock to Buy InsteadOver the past six months, Progyny has been a great trade, beating the S&P 500 by 5.2%. Its stock price has climbed to $25.68, representing a healthy 16.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons ADSK is Risky and 1 Stock to Buy InsteadAutodesk currently trades at $297.44 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 11.2% gain during that period.
3 Reasons POWL Has Explosive Upside PotentialWhat a time it’s been for Powell. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $318.00 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons APPN is Risky and 1 Stock to Buy InsteadAppian’s 16.3% return over the past six months has outpaced the S&P 500 by 5%, and its stock price has climbed to $35.42 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid CADE and 1 Stock to Buy InsteadOver the past six months, Cadence Bank has been a great trade, beating the S&P 500 by 16.8%. Its stock price has climbed to $42.80, representing a healthy 28% increase. This run-up might have investors contemplating their next move.
Renasant (RNST): Buy, Sell, or Hold Post Q3 Earnings?Over the last six months, Renasant’s shares have sunk to $35.22, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 11.2% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Live Oak Bancshares (LOB): Buy, Sell, or Hold Post Q3 Earnings?Live Oak Bancshares has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.1% to $34.35 per share while the index has gained 11.2%.
